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Abstract
Background: CD133 is a cell surface marker of haematopoietic stem and progenitor cells.
Leukaemia inhibitory factor (LIF), sustains proliferation and not differentiation of embryonic stem
cells. We used CD133 to purify adult human retinal cells and aimed to determine what effect LIF
had on these cultures and whether they still had the ability to generate neurospheres.
Methods: Retinal cell suspensions were derived from adult human post-mortem tissue with ethical
approval. With magnetic automated cell sorting (MACS) CD133+ retinal cells were enriched from
post mortem adult human retina. CD133+ retinal cell phenotype was analysed by flow cytometry
and cultured cells were observed for proliferative capacity, neuropshere generation and
differentiation with or without LIF supplementation.
Results: We demonstrated purification (to 95%) of CD133+ cells from adult human postmortem
retina. Proliferating cells were identified through BrdU incorporation and expression of the
proliferation markers Ki67 and Cyclin D1. CD133+ retinal cells differentiated whilst forming
neurospheres containing appropriate lineage markers including glia, neurons and photoreceptors.
LIF maintained CD133+ retinal cells in a proliferative and relatively undifferentiated state (Ki67,
Cyclin D1 expression) without significant neurosphere generation. Differentiation whilst forming
neurospheres was re-established on LIF withdrawal.
Conclusion: These data support the evidence that CD133 expression characterises a population
of cells within the resident adult human retina which have progenitor cell properties and that their
turnover and differentiation is influenced by LIF. This may explain differences in retinal responses
observed following disease or injury.
Background
Neurospheres can be reliably generated from post-mor-
tem adult human retina irrespective of post-mortem time
(up to 48 hours) or age of donor [1-3]. This implies that
the adult human retina may possess an inherent ability for
cellular replacement throughout life. To this aim we have
a presence of somatic progenitor cells, within adult
human tissue, which unlike stem cell populations previ-
ously described for the retina, have limited potential but
are responsible for cell renewal via differentiation into
mature functioning cells. Progenitor cells divide rarely [4-
6] but are likely to be stimulated to proliferate in the event
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genitor cells are thought to differ from stem cells in that
their proliferation is most likely asymmetric i.e. where
some cells retain the properties of the parent cell and
some begin the process of differentiation into mature cells
[8]. The progenitor cells that we are studying within the
retina are observed to have a reduced proliferation rate
and generate neurospheres containing cells at different
stages of differentiation [2]. This cannot be compared to
the hallmarks of stem cells which have a high rate loga-
rithmic expansion of totipotent cells usually associated
with embryonic tissue but more recently identified within
adult neural tissue [8]. Cell-cell, cell-matrix, cognate and
soluble growth factor and cytokine-mediated regulation
of cell may maintain retinal progenitor cells in an arrested
or quiescent state with very low turnover [4-10]. In order
to therapeutically support or facilitate progenitor cells
roles in regeneration of adult retina following inflamma-
tion, degeneration or damage, further understanding of
the control of cell turnover is required. The isolation or
enrichment of this population of cells is therefore an
important objective for this avenue of research. To date a
few cell markers have proved suitable for specifically iden-
tifying, isolating or enriching progenitor cell populations
[4,11]. A common marker for neural tissue progenitors is
the cell surface expression of CD133 [4,12-15]. CD133 is
a pentaspan glycoprotein expressed in the plasma mem-
brane protrusions of cells, first identified on mouse neu-
roepithelial stem cells [16]. In humans CD133 identifies
haemopoietic stem and progenitor cells that may also
express the stem cell marker CD34 [17,18]. Although the
function of CD133 in stem/progenitor cells is unknown,
it is expressed in a wide range of tissues throughout the
body [19]. Within the retina CD133, human prominin
(mouse)-like 1 (PROML1, previously known as AC133
antigen) is concentrated in the membrane evaginations at
the base of rod photoreceptor cell outer segments, (from
where photoreceptor discs are formed) and in the absence
of retinal prominin 1/CD133, photoreceptor degenera-
tion occurs [20]. CD133 expression in undifferentiated
cells has been utilised to identify, isolate and enrich stem
cells [19,21] and neural progenitor from the developing
and adult brain [4,12-15,22]. In these systems CD133+
progenitor cells generated primary and secondary neuro-
spheres (demonstrating potential for passage) [22]. Fur-
thermore CD133+ cell populations showed potent
engraftment, proliferation, migration, and neural differ-
entiation ability [14,15,22].
Following injury or damage, neural tissue responds with
production of growth factor, neutrotrophins and
cytokines including the mitogen, leukaemia inhibitory
factor (LIF). LIF is a member of the IL-6 cytokine family
that maintains stem cells in an undifferentiated state and
promotes stem cell renewal [23]. In the adult rodent
brain, LIF is localised to neurons within the olfactory sen-
sory layer [24,25] and is upregulated in injury or tissue
damage enhancing neural progenitor cell turnover [26].
LIF signals via gp130, (associated with LIF receptor) driv-
ing progenitor cells to re-enter the cell cycle [26,27].
Although LIF maintains neural stem cell turnover
observed in vivo, exogenous LIF promotes gliogenesis
alongside enhanced neurosphere production in vitro [27].
The actions of LIF may therefore vary in different contexts.
The data presented demonstrate successful purification of
adult human progenitor cells through magnetic separa-
tion using the stem cell marker CD133. Purified cultures
were assessed in the presence of growth factors and
cytokines (FGF2 and LIF) for proliferative ability (markers
of division), neurosphere generation and cell differentia-
tion and phenotype. The role of exogenous LIF in main-
taining retinal progenitor cells in culture (preventing
neurosphere generation and differentiation) was also
addressed. CD133+retinal cells showed increased prolifer-
ation in the presence of LIF as measured by BrdU incorpo-
ration, Ki67 and Cyclin D1 expression. CD133+ retinal
cells were efficient in forming neurospheres, which was
suppressed in the presence of LIF and restored again by
LIF removal, without any demonstrable change in their
differentiation capacity within neurospheres.
Methods
Preparation of tissue
Research on human retinal tissue was carried out in com-
pliance with the Helsinki Declaration. Donor tissue was
obtained from Bristol Eye Bank after the removal of the
cornea for transplant was used with research consent and
ethical approval (Central and South Bristol Research and
Ethics project number E5866) and R and D approval
(United Bristol Healthcare project number OP/2004/
1734). As previously reported, the retina was removed
from donor eyes [1-3]. Post mortem times varied between
20 and 48 hours which does not alter the ability of pro-
genitor cell cultures to generate neurospheres [3].
Immunohistochemistry of retinal sections
Whole neural retina was removed from donor eyes and
washed in cell culture medium to remove any contami-
nating retinal pigment epithelium (RPE) and then fixed in
1% paraformaldehyde for 2 hours at room temperature.
After washing in PBS, whole neural retina was snap frozen
in tissue tek (OCT) freezing matrix (Sakura, EU) in liquid
nitrogen vapour. 3 × 12 μm sections were cut and cap-
tured on each poly-l-lysine coated slides. To stain, slides
were immersed in PBS to rehydrate prior to adding the pri-
mary antibody (CD133, 1 μg/ml Miltenyi biotec, UK) for
overnight incubation at 37°C and labelled with Alexa
Fluor® 488 & 594 (Molecular Probes Inc, USA 1 μg/ml)
secondary antibodies for 1 hour at room temperature. ForPage 2 of 18
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(Nestin, 2.5 μg/ml, R & D Systems, UK; Notch-1, 2.5 μg/
ml, eBioscience, Europe and Pax-6, 4 μg/ml, Santa Cruz,
UK). Actin was labelled on slides using rhodamine phal-
loidin (Molecular Probes Inc, USA 1 μg/ml) and counter-
stained with DAPI (Vector Shield Laboratories, UK).
Slides were analysed with image capture using a Leitz
(Dialux 22EB; Leica, Europe) fluorescent microscope.
CD133 magnetic cell purification
Primary retinal cell suspensions were generated using
standard methods [1-3]. Briefly, following exposure to
enzymes (trypsin, collagenase, DNase) and triturated reti-
nal cells were washed in buffer (0.5% FCS, 2 mM EDTA,
PBS, Ph 7.5). After centrifugation the collected pellet was
resuspended in 300 ml of ice cold buffer with 100 μl FcR
block (Miltenyi Biotec, UK) and 100 μl magnetic CD133
(AC133 clone, recognising CD133/1 splice variant) beads
(CD133 microbead kit, Miltenyi Biotec, UK), in accord-
ance with manufacturer's instructions. Bead to cell ratios
for maximal enrichment had been previously titrated to
optimal levels 100 μl beads/1 × 108 cells. Cells were incu-
bated at 4°C for 30 minutes. Cells conjugated to beads
were then washed with buffer and applied onto a MS col-
umn, in 3 ml of buffer, of a MiniMACS CD133 separation
kit (Miltenyi Biotec, UK). The CD133 depleted cells were
collected as the effluent and the column again washed
again 4 times in 3 ml of buffer to flush out positive cells.
The CD133+ cells collected were then passed down a fresh
column to further purify the cell population (Fig 1A, B).
Thus cell purification resulted on average a 95% CD133+
cell population for all experiments.
Flow cytometric cell surface phenotypic (FACS) analysis
Cell surface phenotype of CD133+ retinal cells and
CD133- cells was assessed by multiparameter flow cytom-
etry (FACS Calibur, BD biosciences). Monoclonal anti-
bodies (mAb) to the following markers were used at
previously titrated optimal dilutions and included:
CD133 (clone AC141 293C3 [CD133/2 splice variant]
recognising epitope 2 of huCD133), CD34, CD45,
CD117 and CD271 (Miltenyi Biotec, UK). Doublecortin
(DBX), Nestin, LIF receptor (LIFR), ABCG2, NCAM and
matched isotype control mAb (R & D Systems, UK). Ki67,
Cyclin D1 (ABCAM, UK)., CRALBP, CD90, GFAP, Vimen-
tin, Rhodopsin and Pax-6 (Santa Cruz UK), Neurofila-
ment M, Oligodendrocyte marker 4 (O4) (Chemicon,
Europe), CD31, Recoverin, NANOG, Notch-1, CD135
(eBioscience, Europe), Glutamine Synthatase (BD trans-
duction Labs, Europe). mAb were directly conjugated with
combinations of APC, FITC or PE or unconjugated abs
were labelled with the secondary antibodies alexa Fluor®
488 & 594 (Molecular Probes Europe). Intracellular anti-
bodies were fixed and permeabilised with BD Cytofix/
Cytoperm™ solution followed by washing with Perm/
Wash buffer (BD Europe).
BrdU was obtained from Pharmingen (Europe) and was
visualised with anti BrdU following DNA denature
(Chemicon, Europe). All flow cytometric analyses were
conducted using FlowJo software (Tree Star, Inc. Oregon
Corporation, USA). FACS data were interpreted as dot
plots and histograms. Dot plots were generated of fluores-
cence mAb staining versus side scatter to display uniform-
ity of cell population and display a horizontal line below
which represent isotype mAb control background fluores-
cence levels. Histograms include percentage of positive
events (number over gate) and levels of mean fluores-
cence intensity (MFI) for specific mAb cell surface expres-
sion (unfilled peaks) plus MFI for isotype control mAb
(Grey filled peaks) (Figure 2, 3, 4).
Affymetrix Analysis
300 ng of RNA were isolated from CD133+ magnetically
sorted cells using RNeasy mini® kit (Qiagen, UK) follow-
ing the manufacturers instructions. RNA was extracted
from TIME 0 CD133+ cells from 4 different eye donors.
RNA quality was assessed using the Nanodrop1000 spec-
trophotometer (Labtech) and the 2100 Bioanalyser (Agi-
lent Technologies). The University of Bristol
Transcriptomics Facility carried out the analysis on
Affymetrix GeneChip® Human Gene 1.0 ST Arrays, using
the Affymetrix whole transcript (W T) assay. Image analy-
sis was carried out in Affymetrix GeneChip Command
Console and probe set summarisation and preliminary
data quality evaluation was carried out using Affymetrix
Expression console software. Further analysis of the data
including negative and positive controls was carried out
using Affymetrix robust multiarray average (RMA). RMA
values are multi-chip model-based relative expressions of
arrays via background correction, log-transformation and
normalization and gene-by-gene processing with robust
median polish of PM values (perfect match) [28-30].
Microarray data discussed in this publication have been
deposited within the NCBI's Gene Expression Omnibus
(GEO Carter D A et al 2009) and are accessible through
GEO Series accession number GSE14733 http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi.
Cell Culture
Following magnetic purification, CD133+ retinal cells
were seeded into T25 flasks at 1 × 106 cells/ml. Primary
retinal cells and run through CD133 depleted cells were
cultured along side CD133+ retinal cells as positive and
negative controls. Cells were cultured in DMEM/nutrient
mix F12 with glutamax-1 (L-Alanyl-L-Glutamine 1:1)
with pyridoxine (DMEM/F12 GIBCO, UK) which was
supplemented with 20 ng/ml FGF2 (SIGMA, UK) and
either neural supplement (N2) (GIBCO, UK) with orPage 3 of 18
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ture conditions were medium containing both FGF2 and
N2 (FGF2/N2) [2,3]. For LIF removal studies, cells were
initially cultured for 3 days within FGF2/N2 supple-
mented with LIF (FGF2/N2-LIF). As LIF has been found to
exert its effects within 72 hours of exposure [30], LIF was
removed from the medium following 3 days in culture by
spinning cells and reseeding them into FGF2/N2 medium
with subsequent culture to generate neurospheres.
Neurosphere Scoring (pre staining)
Neurospheres were counted within flasks following 1–3
weeks in culture. Neurospheres were identified as free
floating balls of cells that were phase bright. Cell aggre-
gates were distinguished by having a dark centre when
observed with a phase contrast microscope and in addi-
tion tended not to be free floating in suspension rather
adherent to the flask.
CD133 expression within adult human retinal and following magnetic CD133 cell sortingFigure 1
CD133 expression within adult human retinal and following magnetic CD133 cell sorting. (A) Frozen semi-thin 
retinal sections demonstrating CD133 expression within the photoreceptor layer (green) X400. Discrete CD133+ cells are 
also identified within the inner nuclear layer (INL, red arrow A) and ganglion cell layer (GCL, red arrow A). Panel B concen-
trates on the OPL and GCL X400 and C represents magnification of the GCL X630 within adult human retina. red arrows 
identify CD133+ cells (D) isotype control. Actin was labelled with rhodamine phalloidin and nuclei were counterstained with 
DAPI. Scale bars represent 0.5 μm (A, B, D) and 0.1 μm (C). Magnetic bead tagged -CD133 was used to isolate CD133+ cells 
from primary retinal cell suspension via positive selection (E) CD133+ expression was confirmed by flow cytometry in primary 
retinal cell culture (~67%) and is represented here as a FACS dot plot (grey) and following CD133+ purification.(~96% purity) 
cells display varying extent of expression (black). (F) Histogram to show the increase in CD133+ cells (black line) following 
magnetic separation from primary suspension (dotted line). The Grey filled peak represents isotype mAb fluorescence (0.82%).Page 4 of 18
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Neurospheres were fixed in 1% paraformaldehyde for 20
minutes at room temperature and then washed with PBS
(spinning for 7 mins @ 2500 rpm × 2). Human FcR block
(Miltenyi Biotec, UK) and diluted Primary antibodies
were added and incubated overnight at 4°C. Antibodies
used included: GFAP (Chemicon USA 1 μg/ml), Neurofil-
ament M (NF, Chemicon, USA 5 μg/ml), Nestin (Chemi-
con, US 10 μg/ml) and doublecortin (DBX, R & D 1 ng/
ml). After washing with PBS, cells were incubated with
Alexa Fluor® 488 & 594 (Molecular Probes Inc, USA 1 μg/
ml) secondary antibodies for 1 hour at room temperature.
For dual staining, second specific mAb were added as
above. Neurospheres were finally air dried onto a slide
and nuclei were counterstained with DAPI. Slides were
viewed and marker expression analysed using a Leitz
(Dialux 22EB; Leica, Europe) fluorescent microscope at
×40 magnification. Images were taken using a Leica
flow cytometric analysis of CD133+ retinal cellsFigure 2
flow cytometric analysis of CD133+ retinal cells. Fluorescent histograms showing relative expression of stem/progenitor 
cell markers NESTIN (A), CD135 (B), CD90 (C), CD271 (D), NCAM (E), Pax-6 (F), ABCG2 (G), DBX (H), RHOD (I), GFAP 
(J), LIFR (K), Notch-1 (L), RECOVERIN (M), CD31 (N), CD45 (O), CRALBP (P), VIMENTIN (Q), CD34 (R), cd117 (S) and 
NANOG (T) in CD133+ sorted retinal cells. Grey filled peaks are isotype mAb background fluorescence for each specific mAb 
investigated. Numbers within peaks refer to mean fluorescent intensity (MFI), numbers above bars refer to positive percentage 
expression. The Correspondingly CD133+retinal cells have a phenotype of Nestinhi, CD135hi, CD90hi, CD271hi, NCAMhi, Pax-
6hi, DBXlo, RHODlo, GFAPlo, LIFRlo, Notch-1lo, RECOVERINlo and CD31-, CD45-, ABCG2l-, CRALBP-, VIMENTIN-, CD34-, 
CD117-, NANOG.Page 5 of 18
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CD133+ retinal cells expression of proliferation markers following culture with FGF/N2 and FGF-LIF overnightFigure 3
CD133+ retinal cells expression of proliferation markers following culture with FGF/N2 and FGF-LIF overnight. 
CD133+ retinal cells following culture overnight with either FGF/N2 or FGF-LIF were analysed by flow cytometry for the 
expression of the proliferation markers Ki67, Cyclin D1 or BrdU incorporation.(A) Histograms show the expression of Ki67 
(AI) and Cyclin D1 (AII) after culture with FGF/N2 (dotted line) or FGF-LIF (dashed line) compared to expression immediately 
following CD133+ retinal cell isolation (black line) against isotype control (Grey filled peaks). LIF within cultures causes an 
increase in expression of cell proliferation markers. Figure AIII shows incorporation of BrdU within cells following culture 
overnight with FGF/N2 (dotted line) or FGF-LIF (dashed line) indicating the generation of newly formed cells. (B) Dot plot 
demonstrates gated CD133+ Nestin+ events presented as mAb fluorescence against side scatter. CD133+Nestin+ and Nestin-
CD133+ retinal cells were analysed for coexpression of Ki67 (I, III) or Cyclin D1 (II, IV). At time 0, Nestin positive cells 
expressed higher levels of proliferation markers Ki67 (I 5.90%, MFI 19.91) and Cyclin D 1 (II 12.01%, MFI.22.11) than nestin 
negative cells (Ki67 III Ki67 2.10%, MFI 11.19 and Cyclin D 1 IV 9.50%, MFI 19.07). Purified cells directly ex vivo (black line), cul-
ture overnight with FGF/N2 (dotted line) or FGF-LIF (dashed line).
BMC Ophthalmology 2009, 9:1 http://www.biomedcentral.com/1471-2415/9/1(Europe) AOBS SP2 confocal imaging system attached to
a Leica DM IRE2 inverted epifluorescence microscope.
Neurosphere Scoring (post staining)
Following staining, neurospheres were identified as dapi
postitive balls of cells containing more then 4 cells.
Within each neurosphere the number of dapi positive
cells was counted and positive staining of markers was
noted for each cell. Ten fields of view were counted for
each slide and approximately 5 slides from different
experiments were assessed.
ELISA
Determining LIF concentrations within culture superna-
tants was assessed using human LIF Quantikine® (R & D
systems, UK) as per manufacturer's instructions. In brief,
duplicate of samples and LIF standards (serially diluted in
phosphate buffer) were added to 96 well plate pre-coated
with mouse-anti human LIF mAb. The plate was incu-
bated at room temperature for 1 hour. A Wash buffer
(containing 0.05%Tween-20) was used between steps. LIF
conjugate was added to each well and incubated for 1
hour at room temperature. Substrate solution was added
for 30 minutes then within 30 minutes of stopping the
reaction the absorbance was read at 450 nm corrected to
570 nm using a SpectraMax spectrophotometer (Molecu-
lar Devices, USA), pre-blanking with assay diluent. Soft-
Max Pro software (Molecular Devices, USA) was used for
analysis and transformation to generate a standard curve
and cytokine concentration was then determined using
computer software Excel (Microsoft®). Each ELISA was
repeated at least three times in independent experiments
and results expressed as a mean. ± SEM.
Statistical Analysis
Analysis was performed using StatView® from the SAS
Institute Inc (USA). Non parametric tests were used to
analyse all data. Neurosphere generation was first cor-
phenotype of CD133+ retinal cells following 24 hour cultureFigure 4
phenotype of CD133+ retinal cells following 24 hour culture. The Figure demonstrates histograms of gated CD133 
events showing relative expression of stem/progenitor cell markers that change when cells are cultured with either FGF/N2 or 
FGF-LIF overnight. Expression of Notch-1 (A), CD135 (B), CRALBP (C), Nestin (D), Pax-6 (E), DBX (F) changed on CD133+ 
retinal cells following culture overnight with FGF/N2 (dotted line) or FGF-LIF (dashed line). Grey filled peaks are isotype mAb 
background fluorescence for cells cultured in FGF/N2 as MFI did not significantly change when cells were cultured in either cul-
ture condition.Page 7 of 18
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100000). Mann Whitney testing was used to look at 2
group data and Kruskall-Wallis tests were used to look at
3 group data.
Results
Isolation of CD133+ retinal cells from post-mortem human 
retina
In post mortem adult human, CD133+ expression is dis-
tributed within the photoreceptor layer of retina (Figure
1A) as well as discrete cells within the inner nuclear layer
(INL) and ganglion cell layer (GCL) (Figure 1B–C). FACS
analysis of retinal cell suspensions, demonstrated CD133
expression on approximately 67% of cells, including pro-
minin-1 expressing photoreceptor cells [21,22]. Magnetic
separation using CD133-conjugated beads allowed purifi-
cation of the primary retinal cell suspension (Figure 1E–
F). The CD133+ retinal cells, (initially including CD133+
photoreceptors), were purified by 31.2 ± 2.4% (n = 10).
Starting with average of 5 × 106 primary retinal cells, post
CD133-isolation a purity of 95% CD133+ retinal cells was
achieved. FACS dot plots showed that post-sort a change
in the cell scatter (Figure 1E) and increase in cell counts
(Figure 1F).
Phenotype of CD133+ retinal cells directly ex vivo and 
following culture supplemented with LIF
Initially we characterised the phenotype of CD133+ and
CD133- cell populations following magnetic sorting at
time 0 in culture by flow cytometry. CD133- cell popula-
tions showed no significant expression of stem cell mark-
ers but expressed high levels of differentiated cell markers
including photoreceptors (rhodopsin), neurons (neuro-
filament), ganglion cells (CD90), Muller glia cells
(CRALBP) and glial cells (GFAP) plus low levels of other
heamopoeitic cell markers (CD45, CD31 and CD34) (see
additional file 1). CD133+ retinal cells showed relative
expression of stem/progenitor cell markers (Figure 2) [31-
35]. CD133+ retinal cells expressed high levels of Nestin
(Figure 2A, 80.14%, MFI 331, isotype control 13.07),
CD135 (Figure 2B, 43.95%, MF1 92.40, isotype control
3.52), CD90 (Figure 2C, 58.20%, MFI 703.36 isotype con-
trol 7.03), CD271, (Figure 2D, 64.08, MFI 77.71, isotype
control 4.98), NCAM, (Figure 2E, 20.23%, MFI 514.09,
isotype control 68.82), Pax-6 (Figure 2F, 61.16, MFI
41.09, isotype control 4.79), and low levels of DBX (Fig-
ure 2H, 11.98%, MFI 31.22, isotype control 4.79), GFAP
(Figure 2J, 11.17%, MFI 62.98, isotype control 29.50),
Rhodopsin (Figure 2I, \20.26%, MFI 30.98, isotype con-
trol 4.79), LIFR (Figure 2K, 10.51%, MFI 14.45, isotype
control 4.98), Notch-1 (Figure 2L, 18.22%, MFI 16.42,
isotype control 4.79), Recoverin (Figure 2M, 20.16%, MFI
20.23, isotype control 4.98). The CD133+ retinal cells did
not express significant levels of CD31 (Figure 2N, 5.52%
MFI 17.68, isotype control 4.98), CD45 (Figure 2N,
2.68%, MFI 10.09, isotype control 4.98) and ABCG2 (Fig-
ure 2G, 1.76% MFI 50.67, isotype control 13.02), and
were negative for CRALBP (Figure 2P, 0.15%, MFI 25.05,
isotype control 25.20), VIMENTIN (Figure 2Q, 0.93%,
MFI 14.98, isotype control 4.79), CD34 (Figure 2R,
2.30%, MFI 7.13, isotype control 5.12), CD117 (Figure
2S, 4.18%, MFI 8.96, isotype control 5.18) and, NANOG
(Figure 2T, 0.5%, MFI 5.41, isotype control 3.81) plus O4
(0.2%), NF-M (0.16%) and Glutamine synthatase
(0.05%) (results not shown). In summary CD133+ retinal
cells purified from adult human retina have a phenotype
of Nestinhi, CD135hi, CD90hi, CD271hi, NCAMhi, Pax-6hi,,
DBXlo, Rhodopsinlo, GFAPlo, LIFRlo, Notch-1lo, RECOV-
ERINlo, and CD31-, CD45- ABCG2-, CRALBP-, VIMENTIN-
, CD34-, CD117-, NANOG-, O4-, NF-M-, Glutamine Synt-
hatase-. The expression of the proliferation markers were
assessed on CD133+ retinal cells (Figure 3). Low level
expression of Ki67, 27.37%, MFI 19.99, isotype control
4.98 (Figure 3A, I) and Cyclin D1, 15.83%, MFI 16.89,
isotype control 4.98 (Figure 3AII) was found following
isolation from the tissue (Time 0). Figure 3B displays Nes-
tin+ CD133+ (Figure 3B, I & II) and Nestin-CD133+ (Figure
3B III & IV). Nestin+ CD133+ (Figure 3B I – II) retinal cells
are also positive for Ki67 (5.90%, MFI 19.91) and Cyclin
D1 (12.01%, MFI.22.11), isotype control (1.31% MFI
4.98). Nestin-CD133+ retinal cells expressed reduced lev-
els of proliferation markers (Ki67 2.10%, MFI 11.19, Cyc-
lin D 9.50%, MFI 19.07. Confirmatory transcriptonomic
analysis supported the gene expression profile of CD133+
cells; displaying correspondence between detection of
mRNA expression and protein expression determined by
FACS analysis, including the proliferation markers Ki67
and Cyclin D1 (table 1) [28-30].
Change of CD133+ retinal cell phenotype following 
overnight culture with FGF/N2 or FGFN2-LIF
Figure 4 displays flow cytometric histograms following 24
hour culture in the presence of FGF2/N2 and with LIF sup-
plementation. Following culture with FGF/N2-LIF for one
day CD133+ retinal cells which alters their expression of
Nestin, CRALBP, DBX, Notch-1, Pax-6 and CD135 (Figure
4A–F). The effect of LIF on CD133+ retinal cells causes a
more pronounced increase in expression of Notch-1,
CD135 and the Müller glia cell marker CRALBP (Figure 4
A–C). Conversely, culture overnight with FGF/N2 causes
a more pronounced increase in Nestin, DBX and Pax-6
(Figure 4 D–F). Proliferation markers were also upregu-
lated following incubation with LIF overnight Ki67,
51.54%, MFI 37.98, isotype control 4.98 (Figure 3AI) and
Cyclin D1, 10.02%, MFI 24.83, isotype control (Figure
3AII). In addition FACS analysis revealed BrdU incorpora-
tion in CD133+ retinal cells cultured with LIF overnight
(7.16%, MFI 26.32, isotype control 4.98 Figure 3A III)
overnight.Page 8 of 18
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Table 1: expression data for CD133+ retinal progenitor cell phenotype
mRNA Description Mean Expression
Homo sapiens prominin 1 (PROM1), mRNA. 6795
Homo sapiens nestin (NES), mRNA. 215
Homo sapiens fms-related tyrosine kinase 3 (FLT3), mRNA. (CD135) 66
Homo sapiens Thy-1 cell surface antigen (THY1), mRNA. (CD90) 390
Homo sapiens nerve growth factor receptor (TNFR superfamily, member 16) (NGFR), mRNA. (CD271) 542
Homo sapiens neural cell adhesion molecule 1 (NCAM1), transcript variant 2, mRNA. 1987
Homo sapiens paired box 6 (PAX6), transcript variant 1, mRNA. 788
Homo sapiens ATP-binding cassette, sub-family G (WHITE), member 2 (ABCG2), mRNA. 146
Homo sapiens doublecortex; lissencephaly, X-linked (doublecortin) (DCX), transcript variant 1, mRNA. 258
Homo sapiens rhodopsin (RHO), mRNA. 16078
Homo sapiens glial fibrillary acidic protein (GFAP), mRNA. 637
Homo sapiens leukemia inhibitory factor receptor alpha (LIFR), mRNA. 1737
Homo sapiens Notch homolog 1, translocation-associated (Drosophila) (NOTCH1), mRNA. 326
Homo sapiens recoverin (RCVRN), mRNA. 10323
Homo sapiens platelet/endothelial cell adhesion molecule (CD31 antigen) (PECAM1), mRNA. 188
Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript variant 1, mRNA. (CD45) 38
Homo sapiens retinaldehyde binding protein 1-like 1 (RLBP1L1), mRNA (CRALBP1) 256
Homo sapiens vimentin (VIM), mRNA. 2709
Homo sapiens CD34 molecule (CD34), transcript variant 2, mRNA. 123
Homo sapiens KIT ligand (KITLG), transcript variant b, mRNA. (CD117) 136
Homo sapiens Nanog homeobox (NANOG), mRNA. 111
Homo sapiens neurofilament, medium polypeptide 150 kDa (NEFM), transcript variant 1, mRNA. 662
Homo sapiens cyclin D1 (CCND1), mRNA. 369
Homo sapiens antigen identified by monoclonal antibody Ki-67 (MKI67), mRNA. 55
RNA was isolated from magnetically separated CD133+ cells and prepared using the Affymetrix whole transcript (WT) assay. Mean expression 
values represent 3 repeats of actively transcribing genes (GEO series record GSE14733). Although expressivity has varying values with respect to 
extent of protein expression via FACS analysis, we do not make comparisons at this level. Levels of mRNA are not directly proportional to the 
expression level of the proteins [30]. The number of protein molecules synthesized using a given mRNA molecule as a template is highly dependent 
on translation-initiation features of the mRNA sequence. In addition proteins may differ substantially in their in vivo half lives [30].
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CD133+ Cell Suspensions
Given the evidence that in short-term culture, LIF supple-
mentation maintained expression of progenitor cell mark-
ers, we assessed whether LIF maintained retinal
progenitor cells and prevented neurosphere generation
and differentiation. To do this CD133+ and CD133-
depleted cell suspensions were cultured in FGF2/N2 with
or without LIF were compared for neurosphere generation
(Figure 5). Neurosphere generation (expressed as the
number generated per 100000 cells) was greatest in the
presence of FGF2/N2, as previously documented [3].
FGF2/N2 culture supported optimum conditions for neu-
rosphere generation. Additionally we found that CD133+
retinal cells in FGF2/N2 culture generated significantly
more neurospheres than primary cell suspensions after 1
week (117 ± 52 compared with 20 ± 10, P < 0.02 this was
maintained at 2 weeks (261 ± 124 compared with 22 ± 11,
P < 0.003) (Figure 5A). Analysis of LIF concentrations
found them to be correspondingly reduced in CD133+ cell
FGF2/N2 (Figure 5B). At 2 days in culture, all culture
supernatants (primary, CD133+ and CD133-depleted)
contained barely detectable quantities of LIF (< 10 pg/
ml), but over time LIF production increased significantly,
although remaining lower in CD133+ retinal cells, corre-
sponding to their increased ability to generate neuro-
spheres. The ability of CD133+ retinal cells to generate
neurospheres was significantly suppressed in the presence
of exogenous LIF at greater concentrations than those ever
generated in culture (100 ng/ml vs. 100 pg/ml respec-
tively) (following 2 weeks FGF2-LIF 23 ± 9, FGF2/N2-LIF
28 ± 11 P < 0.05) (Figure 5A).
FGF2/N2 optimises generation of neurospheres from CD133+ retinal cellsigure 5
FGF2/N2 optimises generation of neurospheres from CD133+ retinal cells. Primary, CD133+ and CD133 depleted 
cells were cultured for 1 week, post-sort, with FGF2, FGF2/N2, FGF2-LIF and FGF2/N2 -LIF. Non parametric statistical analysis 
for neurosphere generation at 1 week (A) Neurosphere generation was enhanced when cells were cultured in FGF2/N2: At 1 
week † Primary:CD133+:depleted P < 0.02, * Primary:CD133+ P < 0.02 (n = 14). At 2 weeks: † Primary:CD133+:depleted P < 
0.01, *Primary:CD133+ P < 0.03 (n = 10). Neurosphere generation/100000 was significantly reduced in the presence of LIF (§ ¤ 
P < 0.05).(B) Supernatants from CD133+ cultures were removed following 2 days, 1 week and 2 weeks and analysed for LIF 
production (pg/ml). LIF (pg/ml) increased over 2 weeks. However it was noted that CD133+ retinal cells contained less LIF (pg/
ml) over 2 weeks in culture which corresponded to increased neurosphere generation.Page 10 of 18
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to optimum levels
To assess whether the above mentioned LIF suppression
of neurosphere generation was reversible, after 3 days in
culture with FGF2/N2-LIF, LIF was removed by spinning
cells and replacing medium with that for optimum neuro-
sphere generation, FGF2/N2 (Figure 6). Within 7 days
neurosphere generation by CD133+ retinal cells, that had
initially been exposed to LIF, recovered significantly (P <
0.05) and this remained true at 2 weeks (P < 0.03, Fig 6).
CD133+ retinal cells generated significantly more neuro-
spheres/100000 cells when compared to primary cell cul-
ture at 2 weeks following LIF removal (P < 0.04, Fig 6)
however neurosphere generation did not recover to opti-
mum levels found when culturing cells with FGF/N2.
Neurospheres Express Retinal Cell and Progenitor Cell 
Markers
After 2 weeks in culture neurospheres cultured in FGF2/
N2 were compared with neurospheres cultured initially in
FGF2/N2-LIF followed by LIF removal (see above). The
neurospheres were stained for cell-type specific markers
(GFAP, NF and Rhodopsin) to identify differentiated cells
of glial, neuronal and photoreceptor cell lineage, as well
as Nestin and DBX to identify less differentiated cells (Fig-
ure 7). Within each neurosphere, the number of nuclei
withdrawal of LIF does not recover neurosphere generation in CD133+ retinal cells to optimum levelsFigure 6
withdrawal of LIF does not recover neurosphere generation in CD133+ retinal cells to optimum levels. Following 
the observation that LIF in the culture medium prevented CD133+ retinal cells from generating neurospheres, LIF was 
removed after 3 days (see methods) by spinning down the cells and the medium was replaced with FGF2/N2 which was found 
previously to have a significant effect on neurosphere generation (Fig 4). After 1 week in culture with FGF2/N2 neurosphere 
generation increased significantly – †Primary P < 0.02 (n = 10) * CD133+ P < 0.03 (n = 10). After 2 weeks in culture CD133+ 
retinal cells were found to show a significant difference in neurosphere generation/100000 cells at 1 week §P < 0.02. CD133+ 
retinal cells generated a significant number of neurospheres/100000 cells when compared to primary cultures at 2 weeks ‡ P < 
0.04.Page 11 of 18
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neurospheres express retinal cell and stem cell markersFigure 7
neurospheres express retinal cell and stem cell markers. Confocal Images of Neurospheres Generated from CD133+ 
retinal cells cultured in FGF2/N2 A Neurosphere expressing Nestin+ (red) and DBX+cells (green X630) B Neurosphere 
expressing NF+ (red) and DBX+ cells (green) X630. C Neurosphere expressing Nestin+(red) and GFAP+ cells (green X400). D 
Neurosphere expressing Nestin+ (red) and RHOD+ cells (green X400). Nuclei counterstained with DAPI (blue). Neurospheres 
stained with isotype control antibodies did not have any significant fluorescent staining (E, X630, F, X630). Scale bars represent 
5 μm (A, B, E) and 10 μm (C, D, F). Histograms represent the distribution of nuclei within neurospheres that have been gener-
ated within (G) FGF2/N2 and (H) FGF2/N2 following LIF removal (see methods). Neurospheres generated with pre exposure 
to LIF had significantly more nuclei within each neurosphere (P < 0.05).
BMC Ophthalmology 2009, 9:1 http://www.biomedcentral.com/1471-2415/9/1were counted and each nucleus was assessed for positive
staining as above. This quantification of both dual and
single stained cells within each neurosphere allowed for
both cell counts as well as semi-quantification of differen-
tiation within neurospheres. Neurospheres generated
within FGF2/N2 and FGF2/N2 following LIF removal
contained cells of different lineages and did not contain
significantly different mean numbers of glial, neurons and
photoreceptors (FGF2/N2 36.6 ± 10.2, FGF2/N2 follow-
ing LIF removal 30.5 ± 10.2) (Figure 7A–D). Neuro-
spheres were found to contain cells with the
developmentally regulated cytoskeletal proteins Nestin
and/or DBX, both markers of multi-lineage progenitor
cells [35-38]. At 3 weeks in culture, nuclear counts per
neurosphere were on average 9 ± 1 in CD133+ cell cultures
in FGF2/N2. 13 ± 1 in FGF2/N2 when previously supple-
mented with LIF (Figure 7G, H; p < 0.0001). Initial expo-
sure to LIF generated significantly larger neurospheres
without influencing the differentiated cell types present
within the sphere, although the overall number of neuro-
spheres remained lower.
Discussion
We have shown previously that the adult human retina
contains potential progenitor cells, which although an
infrequent cell type and likely to be distinct or potentially
derived from stem cell niches described in ciliary body
[39], can be cultured regardless of donor age or post mor-
tem time – up to 48 hours [3]. Building on previous
research showing that the retina has potential for repair
and/or regeneration through the presence of specialised
cells [1-3,10,39,40], we have isolated a population of
CD133+ cells from neural adult human retinal which pos-
sess a phenotype and properties that taken together is
highly suggestive of a progenitor cell status. Cohnheim in
1867 coined the concept that stem cells originate within
the blood stream and have the potential to exist in differ-
ent tissues where their proliferative and differentiation
ability is dependent upon the environment which they are
exposed to [8]. Thus these progenitor cells may remain
quiescent and turnover tissue at a rate that is unobserved
due to the restraints of the microenvironment such as seen
within the retina [4-8]. Within the retina, CD133+ cells are
subject to a complex microenvironment, which is likely to
act through cytokines such as LIF and IL-6 and undoubt-
edly other mitogens that may regulate the mitotic activity
and differentitation of these cells into mature cell types.
Through the incorporation of BrdU we have shown that
CD133+ retinal cells do give rise to daughter cells that
have low level proliferative capacity forming neuro-
spheres that contain subset of cells that retain multipo-
tency, expressing retinal cell markers including glial,
neurons and photoreceptors.
Although our research focuses on CD133+ cells within the
retina, the exact origin of these cells remains an open
question. Retinal progenitor cells may be derived from
marrow progenitors, via the circulation (through retinal
vessels, choroidal vessels and crossing Bruch's membrane
or anterior eye structures); arise from a tissue specific pop-
ulation within the eye (or optic nerve) or arise from
changes in other cells e.g. Müller glial or endothelial pro-
genitor cells. The network of elongated Nestin+ cells
within the retina would support the distribution of
migrating progenitors [1] but does not in itself help with
the understanding of the origin of retinal progenitors,
unless these cells themselves are the progenitors. Retinal
stem cells migrate much more widely through the eye if
injected into the vitreous than if injected under the retina
however transplanted neural progenitor cells exhibit
widespread migration into diseased retina [42-44]. Other
groups have identified progenitor cells within the ciliary
body [39,40],, [45-47], peripheral margin of the postnatal
retina [45,46], iris pigment epithelium [50-52] and some
suggest that Müller glial cells within the adult retina pos-
sess progenitor like properties [53,54]. We did not detect
any markers on CD133+ retinal cells to suggest that they
were Müller Glial cells. Their lack of significant expression
of haemopoeitic stem cell markers (CD34, CD117,
ABCG2, CD45) may suggest that these cells are unlikely to
have migrated from bone marrow [55-57].
The use of CD133 in purifying progenitor cells from both
embryonic (murine and human) and adult brain
(murine) is established and recognised [15,22]. The cur-
rent data demonstrate that the same is true for human ret-
inal progenitor cells. Primary cell suspensions from adult
human retina generate more neurospheres per viable cells
after selecting for CD133+ retinal cells. This suggests that
retinal progenitors may have similarity to those from
embryonic brain [4,58]. The data presented demonstrate
that a population of CD133+ retinal cells have a greater
capacity to generate neurospheres (a behaviour associated
with differentiation of cells). Correspondingly FACS anal-
ysis revealed BrdU incorporation within CD133+ retinal
cells when incubated with FGF/N2, supporting the
hypothesis that increases in overall cell numbers in cul-
tures arise from newly generated cells.
The analysis of markers expressed by CD133+ enriched ret-
inal cells is consistent with a progenitor cell phenotype
and is similar to other progenitor cells within the central
nervous system [15,43,58]. As expected CD133+ retinal
cells highly express Nestin, a neural progenitor cell marker
expressed within human retina [1], but in addition, there
was a high expression of CD90, the neural receptor
CD271, the neural adhesion marker NCAM, PAX-6 and
the FIk2/Fit3 tyrosine kinase receptor CD135. PAX-6 is an
important marker as it has a multifunctional role whichPage 13 of 18
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through controlling expression of downstream molecules
which contributes to the multipotency of retinal progeni-
tor cells. Pax-6 influences the expression of the following
transcription factors which ultimately leads to the genera-
tion of specific cell types; Math5, ganglion cells; NgN2,
bipolar cells; Neuro D, amacrine cells; Crx1, photorecep-
tors; Rx1, muller glial cells and Pax-6 acts directly for hor-
izontal cells and is essential for lens formation [59,60].
Previous studies have shown that Pax-6 is also important
for neurosphere generation [61]. In these studies the Pax-
6 gene deletion led to arrested retinal development and
when cells from the optic nerve of these embryos were
harvested, retinal neurospheres failed to develop [61].
This generates a significant role of Pax-6 in the compe-
tence of retinal stem cells and not just retinal develop-
ment [61]. We provide the first description of retinal
expression of CD135 on CD133+ retinal cells, which has
previously only be found to be expressed in fetal and adult
brain, testis and the placenta. It is expressed in popula-
tions enriched for stem cells and primitive uncommitted
progenitors including haemopoietic stem cells [62-64]
and is currently being used as a tool for expanding stem
cell populations [64]. The low and absent expression of
the cells markers rhodopsin, GFAP, CD45, CD31,
CRALBP and CD31 confirm that CD133+ retinal cells
alongside proliferation markers, are at least as subgroups
not differentiated photoreceptors, glial, endothelial or
immune cells.
The CD133 enrichment of adult human retinal cells con-
vincingly enriches retinal neural progenitor cells. In sup-
port of this we noted that CD133+ retinal cells upregulate
their expression of Notch-1 when incubated with LIF
which suggests that LIF would be expected to preserve
undifferentiated progenitor cells in this system. An upreg-
ulation of Notch-1 is critical in the signalling pathway that
preserves a pool of undifferentiated progenitor cells
[65,66]. Low or absent levels of Notch-1 permit cells to
exit the cell cycle and ultimately differentiate. [65,66].
Furthermore increased Notch-1 expression was accompa-
nied by an upregulation of CD135 which as previously
discussed, is also important for stem cell turnover. It is
therefore not surprising that the cell cycle proliferation
markers Ki67 and Cyclin D1 are also upregulated follow-
ing LIF incubation. Cyclin D1 is more closely associated
with promoting photoreceptor development [67]. Con-
versely both Pax-6 and Nestin are upregulated following
incubation with FGF/N2, which seems to support the
development of neurospheres and differentiated cells in
our culture systems. These findings are consistent with
current research on progenitor cell differentiation
[36,61,68,69] As Pax-6 levels increase, progenitor cells
leave the cell cycle and reach a pre-differentiated state
before switching off and terminally differentiating
[62,69]. Low levels of Pax-6 function to maintain progen-
itor cells within the cell cycle [61] which is in agreement
with the lower expression found on CD133+ retinal cells
at time 0 and following LIF incubation. The increased
expression of Nestin in FGF/N2 is not that surprising as
this is where we see optimal neurosphere generation. The
intermediate filament, Nestin has a structure which allows
conformational change and as cellular differentiation is
associated with morphological changes, following expo-
sure to extracellular as well as cellular signals (such as
those associated with the cell cycle), Nestin responds
accordingly [36,69]. In our results we also saw an upregu-
lation of DBX following incubation with FGF/N2. DBX is
a microtubule protein which is generally expressed in
migrating neuronal processes and more recently has been
identified as a marker for neurogenesis [70]. Within our
studies DBX expression could represent the presence of
neuron generation and add more scope to the identity of
CD133+ retinal cells as multipotential progenitors.
In the central nervous system LIF is involved in responses
to injury where expression of LIF increases following brain
injury [26] with enhanced cell turnover and ensuing cell
death and replacement in the damaged area [26]. Studies
on LIF-mediated control of embryonic stem cells have
suggested that self-renewal of cells involves an auto-regu-
latory loop [31]. In low concentrations of LIF, embryonic
stem cells (ESCs) differentiate [31]. ESCs were found to
commit to cell differentiation within the first 36 hours of
LIF deprivation [31,71]. Low levels of LIF maintain cells in
a non-responsive state due to endogenous STAT3 activity
and once cells have lost STAT3 activity; LIF responsiveness
is also lost [31]. Thus cells that have lost LIF-responsive-
ness are committed to differentiation [31], and this would
reflect the findings in our culture system as when LIF is
not added exogenously neurospheres are generated. In
addition the lack of NANOG expression within our
CD133+ retinal cells suggests the need for LIF in order to
self renew [72]. NANOG alleviates the necessity for LIF in
ESC [72]. We found that CD133+ retinal cells respond to
LIF and respond in the manner expected of ESCs and pro-
genitors described previously [27,31,73,32-75]. So when
CD133+ retinal cells were cultured in the presence of exog-
enous LIF; neurosphere generation was reduced. The sup-
pression of neurosphere formation in the presence of LIF
raises the question as to whether, like other neural pro-
genitor cells, it may be possible to expand isolated retinal
progenitor cells ex vivo. A question we hope to address
fully in future work.
Despite our observed effect of exogenous LIF on CD133+
retinal cells, neurospheres generated within the optimum
growth condition FGF/N2 occurred in the presence of low
levels of endogenous LIF. The low levels of LIF at 48 hours
increased to significant levels at 2 weeks. For ESCs, LIFPage 14 of 18
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[31]. Applying this mechanism to CD133+ retinal cells the
level of endogenously generated LIF may initially have
been below the threshold to change the fate of CD133+
retinal cells, thus neurosphere generation ensued. Neuro-
sphere differentiation could not be reversed when LIF was
re-introduced (unpublished observations) [31] and we do
not have any evidence as to which cells generate LIF in our
cultures.
Studies of embryonic neural precursor cells found that
prior exposure to LIF enhances the generation of neuro-
spheres in the presence of appropriate growth factors [31].
Ability to generate neurospheres from purified CD133+
adult human retinal cell suspensions was regained after
LIF removal but did not fully recover to the extent seen in
cells never exposed to LIF, where neurospheres were gen-
erated from CD133+ cells in FGF/N2 alone. The reason
remains unknown but may relate to the rate of cell turno-
ver (which is low for adult human-derived cells). Differ-
ent stem/progenitor cells have different rates of turnover
[4-8,75]; faster turnover is observed with embryonic tissue
and tissue from small species, where there is a high index
of cell division and cell death in differentiated cells [8,75].
Conversely stem cells that turnover slowly and thus divide
infrequently generate long lived differentiated cells; a trait
arguably favourable within adult tissues [8,77]. Pre-expo-
sure to LIF did influence the size of neurospheres gener-
ated; so that they contained significantly more nuclei than
neurospheres simply cultured in FGF2/N2. This was also
found when neurospheres were generated from neural
progenitor cells of postnatal rats that were exposed to LIF
[76]. So although the reason for this is unclear it is not a
unique observation. Autoregulation of LIF levels through
STAT3 could have allowed some CD133+ retinal cells to
remain in an arrested progenitor state. Such cells could
still respond to LIF signalling but reducing the overall
neurosphere numbers as fewer cells have committed to
differentiation? After pre-exposure to LIF, cell types within
neurospheres generated were not different from those
neurospheres generated in FGF/N2 Therefore LIF expo-
sure did not detectably alter cell fate or potential. Neuro-
spheres contained neurons, glial and photoreceptor cells.
Although evidence suggests that LIF enhances self-renewal
by driving a more glial phenotype in differentiated cells
[30,77], we did not observe this in our cultures as relative
numbers of GFAP+ cells were not increased.
Conclusion
These results provide more evidence for the inherent
regenerative ability of the adult human retina. Through
purification of a CD133+ cell population we have demon-
strated that the adult human retina possess cells which
can proliferate and whose phenotypic profile after LIF
exposure is suggestive of progenitor cell status. The simi-
larity of CD133+ retinal cells with other progenitor popu-
lations suggests common themes in the behaviour of
progenitor cells from different sources. Emerging evidence
(paper in preparation) from human retinal neural progen-
itor cells suggests that they respond to other members of
this cytokine family (which includes LIF, IL-6, CNTF and
others). LIF and IL-6 share a common signalling mecha-
nism activating gp130 [77-79]. This makes the study of
the transcriptional targets of LIF/STAT3 an important area
of future study in CD133+ purified adult human retinal
progenitors and suggests a role for LIF in expansion of
these cells. However more understanding is needed in the
control of what maintains the regenerative ability of cells
within the retina and the signals that decide which cells
proliferate and which differentiate. Several signalling
pathways have been suggested including the Oct-4, Wnt/
b-catenin, Notch, BMP (bone morphogenic protein)
[80,81] and sonic hedgehog [7]. Further work into this
area which, will include in depth analysis of microarray
data generated for CD133+ retinal cells (GEO GSE14733)
corroborated by quantitative PCR analysis, will enable us
to understand how disease modifying treatments can be
developed to target these progenitor cells and possible ex-
vivo expansion of retinal progenitor cells for transplanta-
tion within the future [43,44,54,79-81]. We will assess
gene expression within the CD133+ population over time
when exposed to mitogens (including BMPR, noggin,
sonic hedgehog and jagged-1). The data produced will
generate further understanding of the control of these
cells within the neural retina.
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